# Grok Spar — Multi-Model Stakes Protocol (4-Model Pipeline)
**Date:** 2026-03-31
**Tier:** 3
**Chat URL:** https://grok.com/chat?rid=8055bf1b-1212-4d40-ac0b-9be8c282bf90
**Model:** Grok Auto (cross-validate mode)
**Sources:** 149

## VERDICT
> "The 4-model pipeline section is unsound. It rests on three core design errors: (1) empirically contradicted claims of unique OpenAI strengths, (2) unverifiable pricing and uplift numbers, and (3) an unstated but fatal assumption of permanent non-redundancy whose falsification renders the entire addition pointless."

## KILL VECTOR ANALYSIS

### Kill 1: o3-mini "unique gap" claim — [Harper]
**What killed:** The claim that o3-mini uniquely outperforms Claude+Gemini on spec validation / logical consistency. Foundation of the GO decision.
**Kill mechanism:** Capability attack
**Evidence quality:** Primary source (GPQA, SWE-Bench benchmarks 2025-2026) — high weight
**What Grok optimized for:** Evidence-based design
**Decision:** ACCEPT — GO decision collapses. 4th model is overhead if Claude already matches o3-mini on spec validation.

### Kill 2: Per-call pricing fiction — [Benjamin]
**What killed:** "$0.004/call" and "$0.01/call" fixed figures. Non-operational — actual pricing is token-based and varies 100× by prompt length.
**Kill mechanism:** Proxy attack (wrong metric)
**Evidence quality:** Primary source (OpenAI token pricing)
**Decision:** ACCEPT — strip all fixed per-call figures. Replace with: estimate tokens before firing 4th model.

### Kill 3: Kill-vector analysis pipeline placement contradiction — [Lucas]
**What killed:** Step 3 in the 4-model pipeline lists kill-vector analysis as a standalone step, but it's defined elsewhere as part of Grok output processing.
**Kill mechanism:** Internal contradiction
**Evidence quality:** Reasoned argument (document contradicts itself)
**Decision:** ACCEPT — kill-vector analysis is part of step 2 (Grok spar), not a separate pipeline step.

### Kill 4: 4–10% uplift claim domain-specific — [Harper + Benjamin]
**What killed:** The ensemble research cited was from narrow domains (medical papers), not general AI validation pipelines. The claim doesn't generalize.
**Kill mechanism:** Proxy attack (non-comparable domain)
**Evidence quality:** Reasoned argument (no peer-reviewed general-pipeline source found)
**Decision:** ACCEPT — remove specific percentage claim from protocol.

### Kill 5: Latency stacking, no fallback — [Lucas]
**What killed:** 5 sequential API calls across 4 vendors = multi-minute pipeline, rate-limit risk, no timeout or fallback logic.
**Kill mechanism:** Reliability attack + specific failure scenario
**Decision:** ACCEPT — if 4th model is used at all, add a budget gate before firing.

### Kill 6: Permanent non-redundancy assumption — [Lucas] (single fatal assumption)
**What killed:** The entire addition rests on OpenAI maintaining a unique edge over Claude+Gemini. Benchmarks show capability convergence. No deprecation trigger in the protocol.
**Kill mechanism:** Assumption attack
**Evidence quality:** Primary source (2025-2026 convergence data)
**Decision:** ACCEPT — no standing pipeline for a temporary capability gap.

## AGENT CONFLICTS (highest-value output)
- **[Harper] vs original GO rationale:** Harper's benchmark data directly contradicts the "o3-mini uniquely outperforms" claim that justified the GO decision.
- **[Harper + Benjamin] converge:** Both flag the same research basis ("Grok live research 379 sources") as uncited and non-reproducible.
- **[Lucas] adds:** Convergence risk means the entire differentiation argument may be obsolete within 6–12 months.

## NET DECISION: REVISE
**Keep:** openai-cli tool (functional, key in Keychain, cost minimal)
**Revise:** 4-MODEL PIPELINE section — downgrade from standing pipeline to ad-hoc escalation tool
**Strip:** Fixed per-call pricing, 4–10% uplift claim, permanent pipeline framing
**Add:** Deprecation trigger, token-budget gate, concrete trigger criteria
